Low prevalence of copy number variation in pfmdr1 and pfpm2 in Plasmodium falciparum isolates from southern Angola
- PMID: 39794826
- PMCID: PMC11720348
- DOI: 10.1186/s12936-024-05240-2
Low prevalence of copy number variation in pfmdr1 and pfpm2 in Plasmodium falciparum isolates from southern Angola
Abstract
Background: Malaria is the parasitic disease with the highest global morbidity and mortality. According to estimates from the World Health Organization (WHO), there were around 249 million cases in 2022, with 3.4% occurring in Angola. The emergence and spread of drug-resistant Plasmodium falciparum have compromised anti-malarial efficacy and threatens malaria elimination campaigns using artemisinin-based combination therapy (ACT). Increased copy number (CNV) of the P. falciparum gene plasmepsin 2 (pfpm2) have been reported to confer parasite tolerance to piperaquine (PPQ) and the multidrug resistance-1 (pfmdr1), resistance to mefloquine (MEF) and decreased susceptibility to lumefantrine (LUM). PPQ, MEF and LUM are ACT partner drugs. Therefore, CNV detection is a useful tool to track ACT resistance risk. The potential for future treatment failure of artemisinin-based combinations (that include PPQ, LUM and AMQ), due to parasite resistance in the region, emphasizes the need for continued molecular surveillance.
Methods: One hundred and nine clinically derived samples were collected at Hospital Central Dr. António Agostinho Neto (HCL) in Lubango, Angola. qPCR targeting the small-subunit 18S rRNA gene was used to confirm P. falciparum infection. Copy number estimates were determined using a SYBR green-based quantitative PCR assay.
Results: Overall, this study revealed a low number of resistance CNVs present in the parasite population at Lubango, for the genes pfmdr1 and pfpm2. Of the 102 samples successfully analysed for pfpm2 10 (9.8%) carried increased CNV and 9/101 (8.9%) carried increased CNV of pfmdr1.
Conclusions: This study provides, for the first time, evidence for the presence of CNVs in the pfpm2 and pfmdr1 genes in P. falciparum isolates from southern Angola.
Keywords: Plasmodium falciparum; pfmdr1; pfpm2; Angola; Lubango; Lumefantrine; Piperaquine.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: DNA samples were collected following individual oral consent and signed informed written consent from all participants or their guardians. Ethical clearance for the work was obtained from: Comité de Ética Independente da Faculdade de Medicina da Universidade Agostinho Neto and by the Hospital Central Dr. António Agostinho Neto (HCL) institutional ethics review committee (deliberation Nº08/2020, on 14 November 2020). Competing interests: The authors declare no competing interests.
Figures
References
-
- WHO. World malaria report 2023. Geneva, World Health Organization, 2023. https://www.who.int/teams/global-malaria-programme/reports/world-malaria....
-
- White NJ. Malaria. In: Finch RG, Greenwood D, Norrby SR, Whitley RJ (eds.). Antibiotic and Chemotherapy. 9th Edn. Saunders Publ. 2010.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
